Hitinder Singh Gurm

Dr. Hitinder Singh Gurm serves as Professor of Internal Medicine at the University of Michigan Medical School and interim Chief Medical Officer of Michigan Medicine. His clinical expertise centers on interventional cardiology, with specialization in coronary artery disease, carotid interventions, and complex vascular procedures at the Frankel Cardiovascular Center in Ann Arbor.

Dr. Gurm's educational trajectory includes:

• MBBS: Christian Medical College, Ludhiana, India (1992)
• Residency: Internal Medicine, Cleveland Clinic Hospital (1999)
• Fellowship: Cardiovascular Disease, Cleveland Clinic Hospital (2003)
• Fellowship: Interventional Cardiology, Cleveland Clinic Hospital (2005)

His research program drives innovation in PCI safety and device development, focusing on contrast-induced nephropathy mitigation, intracoronary imaging optimization, and novel endovascular technologies like histotripsy and pulsatile lithotripsy. He pioneered registry-based quality improvement through the BMC2 consortium, analyzing statewide PCI outcomes to refine clinical protocols.

Analysis of Dr. Gurm's recent publications reveals dominant themes in real-world PCI safety assessment, calcified lesion management via intravascular lithotripsy, and AI-driven risk prediction. His BMC2 registry work establishes Michigan as a national model for cross-institutional quality initiatives, with significant emphasis on reducing contrast volumes, optimizing discharge care, and managing cardiogenic shock.

Major accolades include:

• Michigan Health & Hospital Association Patient Safety Leadership Award (2016)
• Election to the American Society for Clinical Investigation (ASCI)
• Becker Hospital Review's Top 50 Patient Safety Experts (2018)

As BMC2 leader, Dr. Gurm spearheads Michigan's statewide peer-review system that evaluates 20,000+ annual PCIs, identifying preventable complications and driving protocol standardization. His patented device innovations—particularly in pulsatile balloon catheters and vascular lithotripsy—demonstrate translational research impact, supported by extensive NIH and industry funding reflected in his 250+ publications.

Dr. Gurm directs the Frankel Cardiovascular Center's interventional research team, leveraging the BMC2 registry for real-time quality analytics. Current projects integrate machine learning with PCI outcomes data while advancing histotripsy-based thrombolysis and calcific plaque modification through industry partnerships.